The autophagy-related gene PEA15 is a potential prognostic biomarker for early-stage endometrial carcinoma
- Qiao Qin 1,2, Guoqing Li 1, Jing Cai 1, Sha Hu 1, Liqiong Cai 1
- Qiao Qin 1,2, Guoqing Li 1, Jing Cai 1
- 1Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- 2Department of Ultrasound, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- 0Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Autophagy-related gene PEA15 improves prognostic stratification for early-stage endometrial carcinoma. High PEA15 expression correlates with poorer survival, acting as an independent prognostic biomarker for personalized treatment strategies.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- The Cancer Genome Atlas (TCGA) molecular classification aids endometrial carcinoma risk stratification.
- Microsatellite instability (MSI) and copy-number low (CN-L) subtypes show similar survival outcomes.
- Need for refined prognostic markers in early-stage endometrial carcinoma.
Purpose Of The Study
- Identify autophagy-related molecular signatures for precise TCGA-based prognostic stratification.
- Evaluate PEA15 as an independent prognostic factor, particularly in MSI and CN-L subtypes.
- Correlate PEA15 protein expression with patient survival in early-stage endometrial cancer.
Main Methods
- Univariate and multivariate Cox regression analyses on TCGA cohort.
- Kaplan-Meier survival analysis for candidate autophagy-related genes.
- Immunohistochemical analysis of PEA15 expression in institutional cohort tissue microarrays.
Main Results
- NRG3, PEA15, DNAJB1, BAK1, DRAM1, KLHL24, ATF6, CDKN2A, MBTPS2, and UVRAG associated with survival.
- PEA15 identified as an independent prognostic factor via multivariate analysis.
- Elevated PEA15 expression linked to poorer overall and disease-free survival; confirmed as independent prognostic factor for recurrence in stage I endometrioid adenocarcinoma.
Conclusions
- Autophagy-related gene PEA15 serves as an independent prognostic biomarker in early-stage endometrial carcinoma.
- PEA15 enhances risk stratification between MSI and CN-L subtypes.
- Immunohistochemical detection of PEA15 offers clinical potential for molecular classification and personalized management.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

